pamidronate has been researched along with Gastric Diseases in 1 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Pamidronate is an effective inhibitor of bone resorption; for this reason it is used in the treatment of high bone turnover diseases and osteoporosis." | 2.69 | [Treatment of post menopausal osteoporosis with intravenous pamidronate in patients with esophagogastric pathology]. ( Fradinger, E; Morillo, S; Rey, P; Sarli, M; Zanchetta, J, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sarli, M | 1 |
| Fradinger, E | 1 |
| Morillo, S | 1 |
| Rey, P | 1 |
| Zanchetta, J | 1 |
1 trial available for pamidronate and Gastric Diseases
| Article | Year |
|---|---|
[Treatment of post menopausal osteoporosis with intravenous pamidronate in patients with esophagogastric pathology].
Topics: Aged; Diphosphonates; Esophageal Diseases; Female; Humans; Infusions, Intravenous; Middle Aged; Oste | 1998 |